These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 37436061

  • 1. Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.
    Prajapati KS, Kumar S.
    J Cell Biochem; 2023 Aug; 124(8):1186-1202. PubMed ID: 37436061
    [Abstract] [Full Text] [Related]

  • 2. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
    Prajapati KS, Kumar S.
    Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
    [Abstract] [Full Text] [Related]

  • 3. Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling.
    To NB, Nguyen YT, Moon JY, Ediriweera MK, Cho SK.
    Nutrients; 2020 Jun 03; 12(6):. PubMed ID: 32503225
    [Abstract] [Full Text] [Related]

  • 4. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.
    Zhao Q, Liu Y, Wang T, Yang Y, Ni H, Liu H, Guo Q, Xi T, Zheng L.
    Eur J Pharmacol; 2020 Oct 05; 884():173359. PubMed ID: 32738343
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
    Wang X, Qiu W, Zhang G, Xu S, Gao Q, Yang Z.
    Int J Clin Exp Pathol; 2015 Oct 05; 8(5):5017-25. PubMed ID: 26191195
    [Abstract] [Full Text] [Related]

  • 6. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY, Wang JQ, Wu LL, Zheng WE, Chen PR.
    Breast Cancer; 2020 Jan 05; 27(1):147-158. PubMed ID: 31410735
    [Abstract] [Full Text] [Related]

  • 7. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M, Farzaneh S, Taghikhani A, Zarghi A, Noori S.
    Anticancer Agents Med Chem; 2020 Jan 05; 20(7):875-886. PubMed ID: 31893999
    [Abstract] [Full Text] [Related]

  • 8. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY, Wong G, Earle C, Chen L.
    J Biol Chem; 2012 Sep 21; 287(39):32800-24. PubMed ID: 22847005
    [Abstract] [Full Text] [Related]

  • 9. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
    Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA, Polyak K.
    J Clin Invest; 2011 Jul 21; 121(7):2723-35. PubMed ID: 21633165
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
    Zhang Z, Sun L, Zhang Y, Lu G, Li Y, Wei Z.
    J Cell Physiol; 2018 Nov 21; 233(11):8630-8638. PubMed ID: 29797562
    [Abstract] [Full Text] [Related]

  • 11. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
    Prajapati KS, Shuaib M, Gupta S, Kumar S.
    Mol Carcinog; 2022 Sep 21; 61(9):876-889. PubMed ID: 35770722
    [Abstract] [Full Text] [Related]

  • 12. The Effect of hsa-miR-451b Knockdown on Biological Functions of Gastric Cancer Stem-Like Cells.
    Farahani DB, Akrami H, Moradi B, Mehdizadeh K, Fattahi MR.
    Biochem Genet; 2021 Oct 21; 59(5):1203-1224. PubMed ID: 33725258
    [Abstract] [Full Text] [Related]

  • 13. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J, Zhang X, Zhang Y, Wu B, Fang L, Wang N, Yi H, Chang N, Chen L, Zhang J.
    Exp Cell Res; 2020 Nov 01; 396(1):112288. PubMed ID: 32941808
    [Abstract] [Full Text] [Related]

  • 14. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W, Zhong Z, Luo C, Xiao Y, Li L, Zhang X, Yang L, Xiao K, Ning Y, Chen L, Liu Q, Hu X, Zhang J, Ding X, Xiang S.
    Theranostics; 2019 Nov 01; 9(19):5497-5516. PubMed ID: 31534499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
    Yang Q, Zhao S, Shi Z, Cao L, Liu J, Pan T, Zhou D, Zhang J.
    J Exp Clin Cancer Res; 2021 Apr 06; 40(1):120. PubMed ID: 33823894
    [Abstract] [Full Text] [Related]

  • 18. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A, Maldonado V, Melendez-Zajgla J, Garcia‐Lopez P.
    EMBO Rep; 2016 May 06; 17(5):648-58. PubMed ID: 27113763
    [Abstract] [Full Text] [Related]

  • 19. The inhibition of circular RNA circNOLC1 by propofol/STAT3 attenuates breast cancer stem cells function via miR-365a-3p/STAT3 signaling.
    Liu YP, Heng JY, Zhao XY, Li EY.
    J Transl Med; 2021 Nov 17; 19(1):467. PubMed ID: 34789263
    [Abstract] [Full Text] [Related]

  • 20. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
    Chen Y, Wu N, Liu L, Dong H, Liu X.
    J Cell Mol Med; 2020 Jul 17; 24(13):7353-7369. PubMed ID: 32558224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.